Das CK - Search Results

1

¹⁷⁷Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial.

Satapathy S, Mittal BR, Sood A, Das CK, Mavuduru RS, Goyal S, Shukla J, Singh SK. Satapathy S, et al. Among authors: das ck. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1754-1764. doi: 10.1007/s00259-021-05618-3. Epub 2021 Nov 29. Eur J Nucl Med Mol Imaging. 2022. PMID: 34842950 Free PMC article. Clinical Trial.

2

225Ac-PSMA-617 Radioligand Posttherapy Imaging in Metastatic Castrate-Resistant Prostate Cancer Patient Using 3 Photopeaks.

Vatsa R, Sood A, Vadi SK, Das CK, Kaur K, Parmar M, Mittal BR. Vatsa R, et al. Among authors: das ck. Clin Nucl Med. 2020 Jun;45(6):437-438. doi: 10.1097/RLU.0000000000003031. Clin Nucl Med. 2020. PMID: 32366786

3

Expression of CXCR4 Receptors in Refractory Atypical Mediastinal Carcinoid.

Krishnaraju VS, Satapathy S, Sood A, Das CK, Chatterjee D, Shukla J, Mittal BR. Krishnaraju VS, et al. Among authors: das ck. Clin Nucl Med. 2020 Sep;45(9):e422-e424. doi: 10.1097/RLU.0000000000003177. Clin Nucl Med. 2020. PMID: 32657867

4

Docetaxel-Induced Interstitial Pneumonitis Detected on 68Ga-PSMA PET/CT.

Kumar S, Singh H, Das CK, Kumar R, Mittal BR. Kumar S, et al. Among authors: das ck. Clin Nucl Med. 2021 May 1;46(5):e268-e269. doi: 10.1097/RLU.0000000000003445. Clin Nucl Med. 2021. PMID: 33315676

5

Response to Concomitant Enzalutamide and 177Lu-PSMA-617 Radioligand Therapy in ATM-Mutated Metastatic Castration Resistant Prostate Cancer.

Satapathy S, Das CK, Parihar AS, Sood A, Mittal BR. Satapathy S, et al. Among authors: das ck. Clin Nucl Med. 2021 Jul 1;46(7):582-583. doi: 10.1097/RLU.0000000000003541. Clin Nucl Med. 2021. PMID: 33630794

6

Satapathy S, Mittal BR, Sood A, Das CK, Singh SK, Mavuduru RS, Bora GS. Satapathy S, et al. Among authors: das ck. Indian J Nucl Med. 2020 Oct-Dec;35(4):299-304. doi: 10.4103/ijnm.IJNM_130_20. Epub 2020 Oct 21. Indian J Nucl Med. 2020. PMID: 33642753 Free PMC article.

7

Evolving role of ²²⁵Ac-PSMA radioligand therapy in metastatic castration-resistant prostate cancer-a systematic review and meta-analysis.

Satapathy S, Sood A, Das CK, Mittal BR. Satapathy S, et al. Among authors: das ck. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):880-890. doi: 10.1038/s41391-021-00349-w. Epub 2021 Mar 21. Prostate Cancer Prostatic Dis. 2021. PMID: 33746213

8

Effect of COVID-19 on ¹⁸F-FDG PET/CT: Is There a Need to Consider COVID-19 Status Before Planning ¹⁸F-FDG PET/CT for Oncologic Evaluation?

Kavanal AJ, Jena SR, Kumar R, Das CK, Kumar S, Mittal BR. Kavanal AJ, et al. Among authors: das ck. J Nucl Med Technol. 2021 Sep;49(3):284-285. doi: 10.2967/jnmt.121.262145. Epub 2021 Jul 9. J Nucl Med Technol. 2021. PMID: 34244220 Free PMC article.

9

Alpha Before Beta: Exceptional Response to First-Line 225Ac-DOTATATE in a Patient of Metastatic Neuroendocrine Tumor With Extensive Skeletal Involvement.

Satapathy S, Sood A, Das CK, Kavanal AJ, Mittal BR. Satapathy S, et al. Among authors: das ck. Clin Nucl Med. 2022 Feb 1;47(2):e156-e157. doi: 10.1097/RLU.0000000000003823. Clin Nucl Med. 2022. PMID: 34284478

10

Stereotactic body radiation therapy for metastatic urethral melanoma in a male patient.

Goyal S, Periasamy K, Singh SK, Das CK. Goyal S, et al. Among authors: das ck. J Radiosurg SBRT. 2022;8(1):71-73. J Radiosurg SBRT. 2022. PMID: 35387406 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters